findmyKOL
Clinical trialNCT01748240TerminatedPhase 2Interventional

Addition of Vorinostat to Azacitidine in Higher Risk MDS a Phase II add-on Study in Patients With Azacitidine Failure

SponsorGroupe Francophone des MyelodysplasiesEnrollment21Myelodysplastic Syndrome
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

24 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

France
  • Chu D'Angers

    Angers, France

  • Ch Annecy

    Annecy, France

  • Hôpital Avignon

    Avignon, France

  • Centre Hospitalier de la Côte Basque

    Bayonne, France

  • Hôpital Avicenne

    Bobigny, France

  • Chu de Grenoble

    Grenoble, France

  • Ch Le Mans

    Le Mans, France

  • Ch Lyon Sud

    Lyon, France

  • Ipc-Unité D'Hématologie 3

    Marseille, France

  • Chu Nantes

    Nantes, France

  • Hôpital Archet1

    Nice, France

  • Ghu Caremeau

    Nîmes, France

  • Hopital Cochin-Hematology

    Paris, France

  • Hopital Saint Louis - Ap-Hp, Hematology Dpt

    Paris, France

  • Hôpital Saint Louis

    Paris, France

  • Hôpital Saint-Louis

    Paris, France

  • Centre Hospitalier Joffre

    Perpignan, France

  • Chu de Haut-Lévèque

    Pessac, France

  • Centre Henri Becquerel

    Rouen, France

  • Hopital Purpan-Medecine Interne

    Toulouse, France

  • Hôpital Purpan, Service D'Hématologie Clinique

    Toulouse, France

  • Chu Bretonneau

    Tours, France

  • Ch de Valence

    Valence, France

  • Chu Brabois

    Vandœuvre-lès-Nancy, France

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Mar 2013
Primary completion
31 Oct 2013
Completion
31 Jul 2015
Last update posted
4 Jun 2019
Registered enrollment
21
Registry id
NCT01748240

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.